ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Denali Therapeutics (DNLI)

Technical Analysis Report for USA stock DNLI Denali Therapeutics. Dated: 24 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics then click here. or read Experts views on Denali Therapeutics or Forecast & share price targets of Denali Therapeutics

Denali Therapeutics Opened at 19.45 and Closed at: 19.87, which is 2.11% of previous session's close. It moved within a range of 19.27 and 20.05
The session was a Bullish session with an average volume of 1174200, which is -3.99% of previous session's volumes.

  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 5 days back on short term averages

A Dead cross was found 6 days back on short term averages

A Golden cross was found 7 days back on short term averages

A Golden cross was found 2 days back on mid term averages

Support for tomorrow is 19.57 and resistance for tomorrow is 20.35
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 19.41, 18.95 resistance for tomorrow's hourly charts is 20.19, 20.51

10 Day SMA for Denali Therapeutics (DNLI) is 20.28 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Denali Therapeutics (DNLI) is 19.77 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Denali Therapeutics (DNLI) is 20.17 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 19.4 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Denali Therapeutics is 17.3 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Denali Therapeutics is at 19.77 and 200 DMA is at 17.3, while 50 DMA and 100 DMA are at 20.17 and 19.4 respectively

Denali Therapeutics (DNLI) moving average of 20 SMA is at 19.77 and 20 EMA is at 20.09

Denali Therapeutics (DNLI) moving average of 50 SMA is at 20.17 and 50 EMA is at 19.95

Denali Therapeutics (DNLI) moving average of 100 SMA is at 19.4 and 100 EMA is at 19.27

Denali Therapeutics (DNLI) moving average of 200 SMA is at 17.3 and 200 EMA is at 18.72

Denali Therapeutics has performed better than Penumbra Inc in short term. Holding Denali Therapeutics could be a better choice for now!

Glaukos Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Glaukos Corporation, about 8.32% more returns!

Denali Therapeutics has performed better than Vertex Pharmaceuticals in short term. Holding Denali Therapeutics could be a better choice for now!

Denali Therapeutics has performed better than Sensus Healthcare in short term. Holding Denali Therapeutics could be a better choice for now!

Solid Biosciences has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Solid Biosciences, about 1.97% more returns!

Rhythm Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 3.61% more returns!

Denali Therapeutics has performed better than Rocket Pharmaceuticals in short term. Holding Denali Therapeutics could be a better choice for now!

Oncolytics Biotech has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 10.58% more returns!

Intellia Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 0.6% more returns!

Lantheus Holdings has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Lantheus Holdings, about 3.82% more returns!

Denali Therapeutics has performed better than Kalvista Pharmaceuticals in short term. Holding Denali Therapeutics could be a better choice for now!

Immuron has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Immuron, about 0.46% more returns!

Integra Lifesciences has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Integra Lifesciences, about 5.47% more returns!

Denali Therapeutics has performed better than Fortress Biotech in short term. Holding Denali Therapeutics could be a better choice for now!

Denali Therapeutics has performed better than Enanta Pharmaceuticals in short term. Holding Denali Therapeutics could be a better choice for now!

Denali Therapeutics Technical analysis of indicators

Price action analysis of Denali Therapeutics (DNLI) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Denali Therapeutics in short term but the sell signal is initial and weak.

Denali Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Denali Therapeutics in short term but BUY signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Denali Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 20.37 and Denali Therapeutics DNLI stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Denali Therapeutics DNLI stock. Volume based technical analysis of Denali Therapeutics DNLI stock is negative.

Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And DNLI Experts View which covers a lot of information including buying and selling signals

DNLI future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Denali Therapeutics or View Candle Stick Charts here

Chart Denali Therapeutics (DNLI)  Technical (Analysis) Reports Denali Therapeutics [

Videos related to: Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Denali Therapeutics (DNLI)  Technical (Analysis) Reports Denali Therapeutics [

 

Back to top